What does Qualigen Therapeutics, Inc. do?

Jun 22 2025 07:21 PM IST
share
Share Via
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing cancer and infectious disease treatments and its FastPack diagnostic platform. It has a market cap of $2.58 million and reported a net profit loss of $2 million as of September 2024.
Overview:
Qualigen Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of therapeutic products for the treatment of cancer and infectious diseases, as well as the development of its FastPack diagnostic platform. The company operates within the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap entity.

Financial Snapshot:
Most recent Net Profit: -2 Million (Quarterly Results - Sep 2024)
Market-cap: USD 2.58 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.49
Return on Equity: 342.02%
Price to Book: -1.21

Contact Details:
Address: 1880 Century Park E Ste 1000, LOS ANGELES CA: 90067-1623
Tel: 1 310 2031000
Fax: 1 310 9191600
Website: https://www.qualigeninc.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Qualigen Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:37 AM IST
share
Share Via
How big is Qualigen Therapeutics, Inc.?
Jun 22 2025 06:30 PM IST
share
Share Via